MOJ ISSN: 2379-6294MOJT

Research Article
Volume 1 Issue 3 - 2015
Ameliorative Role of Melissa officinalis against Hepatorenal Toxicities of Organophosphorus Malathion in Male Rats
Mohamed M Sief1*, Farouk A Khalil2, Assem A K Abou Arab1, Mahmoud A Abou Donia1, Ahmed M El-Sherbiny2 and Sherif R Mohamed1
1Department of Food Toxicology and Contaminants, National Research Center, Egypt
2Department of Animal Physiology, Ain-Shams University, Egypt
Received: March 05, 2015 | Published: August 28, 2015
*Corresponding author: Mohamed M Sief, Department of Food Toxicology and Contaminants, National Research Center, Egypt, Tel: 201281052247; Email:
Citation: Sief MM, Khalil FA, Abou-Arab AAK, Abou Donia MA, El-Sherbiny AM, et al. (2015) Ameliorative Role of Melissa Officinalis against Hepatorenal Toxicities of Organophosphorus Malathion in Male Rats. MOJ Toxicol 1(3): 00014. DOI: 10.15406/mojt.2015.01.00014


It has been confirmed that organophosphorus compounds OP altered glucose homeostasis. Considerable experimental and clinical evidences have contributed the beneficial effects of antioxidant compounds in plant extract on hepatorenal toxicity. The aim of this study was to evaluate whether Melissa officinalis extract, was able to ameliorative hepatorenal injury induced by organophosphorus Malathion. Malathion at 27mg/kg bw was administered to rats alone or in combination with Melissa officinalis extract at 200mg/kg bw. Malathion decreases feed intake and body weight as well as liver and kidneys weight. Moreover, Malathion increases the levels of various serum marker enzymes AST, ALT and ALP. A significant increase in the level of serum urea, uric acid and creatinine in response to ML treatment. As well as ML induced increase in MDA in liver and kidneys while induced decreases in the activities of SOD, GPx and CAT. Co-administration of malathion with Melissa officinalis extract resulted in restoration of all tested parameter. These results may be due to the significant increase recorded in acetylcholine esterase (Ach E) activity in-vivo after co administration of malathion and Melissa officinalis extract. In histological study of liver and kidney, Malathion induced damage in liver and kidneys. However, MO administration to ML-treated animals resulted in overall improvement in liver and kidneys damage, emphasizing its antioxidant role. In light of the available data, it can deduce that ML-induced lipid peroxidation, oxidative stress, liver and kidneys damage rats, and conjoint supplementation of MO has resulted in pronounced ameliorating effect in all tested parameter and histological picture of liver and kidney.


OP: Organophosphorus; AST: Aspartate Aminotransferase; ALT: Alanine Transaminase; ALP: Alkaline Phosphatase; SOD: Superoxide Dismutase; GPx: Glutathione peroxidase; AchE: Acetylcholine Esterase; ROS: Reactive Oxygen Species; LPO: Lipid Peroxidation; TBARS: Thio Barbituric Acid Reactive Substances; CAT: Catalase; MDA: Malon Di Aldehyde


The pollution of the environment plays a crucial role in the occurrence of many diseases affecting plants, animals and humans. One of the main factors causing pollution of the environment is the irrational use of organophosphorus pesticides [1]. The World Health Organization estimated that the incidence of pesticide poisoning in developing countries has doubled between 1987 and 1997 [2]. Organophosphorus insecticides are very toxic compounds, intensively used in agriculture. Their existence in the environment is very harmful to human health as they irreversibly inhibit the catalytic active sites of AchE, an essential enzyme that permits the transmission of electric signals in the nervous system of most animal beings.

The OP compound malathion (S-1, 2(bis ethoxycarbonyl) ethyl O, O dimethyl phosphorodithioate) is used extensively throughout the world, especially in developing countries, to control major arthropods in public health programs, animal ectoparasites, human head and body lice, household insects and to protect grain in storage [3].

The toxicity of OP agents may be due, at least in part, to the formation of reactive oxygen species (ROS), leading to lipid peroxidation (LPO), which is generally assessed by an increase in the levels of thio barbituric acid reactive substances (TBARS) [4]. In addition, malathion is a lipophilic substance; it may enhance LPO by directly interacting with the cellular plasma membrane. It is evident that LPO is accompanied by an alteration (inhibition or activation) in the antioxidant defence systemin different organs following acute, sub chronic and chronic exposure to OP compounds [5]. Nevertheless, recent evidence suggests that exposure to different stress models and concentrations (acute, repeated and chronic restraint stress) have an important implication in the alteration of the antioxidant defence system [6]. The liver is the major metabolizing and the most active organ for mediating bio-activation of thiono-organophosphates [7]. It is considered among the primarily targets for malathion toxicity [8].

On the same concern kidney was one of the target organs of experimental animals attacked by acute, sub-chronic and chronic exposure to OP [9]. Besides, it has been postulated that OP produced oxidative stress in different tissues, such as kidney of rats and mice, through the formation of reactive oxygen species (ROS) [10].

Melissa officinalis belongs to the Laminaceae family, being a perennial herb. Preparations derived from the aerial part of M. officinalis are often used in folk medicine for the treatment of fevers and colds, indigestion associated with nervous tension, hyperthyroidism, depression, mild insomnia, epilepsy, headaches, toothaches, flatulence, colic, nausea, nervousness, anaemia, vertigo, syncope, malaise, asthma, bronchitis, amenorrhea, cardiac failure, arrhythmias, depression, psychosis, hysteria, ulcers, wounds, among others [11]. Thus, the present study was designed to investigate of protective effects of Melissa officinalis extract on liver and kidney damage induced by Malathion.

Melissa officinalis L. plant

Arial parts of M. officinalis were obtained from the herbarium, National Research Center, Giza, Egypt.


Preparation of Melissa officinalisextract
The dried arial parts powder of M. officinalis L. (100g) was soaked at room temperature in 1000ml (70% ethanol) and extracted for 1 week. On the seventh day, the ethanolic extract was stirred for 12h and filtered through a Whatman No.1 filter paper, and then solvent was fully evaporated with a rotary evaporator (Panchun Scientific Co.) at 35 °C. The ethanolic extract was freeze dried. The freeze dried extract was dissolved in corn oil (10 g/L), and the dose adjusted at 200 mg/kg bw.

Experimental groups
After an acclimatization period of 1 week, animals were equally divided into four groups (8 rats in each) and housed in filter top polycarbonate cages. Animals were segregated into four groups each group comprised eight animals and treated daily for 90 consecutive days. The selected dose of the insecticide was based on Kalender et al. [12] in which 1/50 LD50 of ML induced biochemical alterations in rats without morbidity.

Body weight, Feed intake, and blood collection
Body weight changes of all rats were recorded daily during the experimental period (90 days), as well as daily feed intake was recorded. At the end of this period, blood samples were collected from the animals under ether anaesthesia by puncturing the retro-orbital venous plexus with a fine sterilized glass capillary. Blood was left for 20min at room temperature, then centrifuged at 3000rpm under cooling for 10min using Hereaeus Labofuge 400R, Kendro Laboratory Products GmbH, Germany, to separate the sera. The sera was kept in a deep freezer (-20 °C) until analysis within 1 week.

Organs weight
After blood collection, rats were sacrificed by cervical dislocation. Liver and kidneys were quickly removed and weighed individually.

Biochemical Estimations

Biochemical parameter in serum

The sera was used for the determination of the Acetylcolinestrase (AchE) Alanineaminotransaminase (ALT), Aspartateaminotransaminase (AST), Alkaline phosphatase (ALP), urea, uric acid, and creatinine according Reitman et al. [13], Belfield et al. [14], Blass et al. [15] respectively.

Antioxidant enzymes in liver and kidneys homogenates
After the collection of blood samples, all animals were sacrificed and samples from hepatic and renal tissues (approximately 0.05–0.1g) were homogenized in phosphate buffer (pH 7.4) to give 20%w/v homogenate [16]. This homogenate was centrifuged at 1700rpm and 4 °C for 10 min; the supernatant was stored at −20 °C until analysis. This supernatant (20%) was used for the determination of the following:

Malondialdehyde (MDA) measurement: The liver and kidneys malondialdehyde concentrations, a lipid peroxidation index, were determined spectrophotometrically according to Draper et al. [17]. Briefly, an aliquot of liver and kidneys extract supernatant was mixed with 1 ml of 5% trichloroacetic acid and centrifuged at 2500g for 10min. An amount of 1ml of thiobarbituric acid reagent (0.67%) was added to 500ml of supernatant and heated at 90 °C for 15min. The mixture was then cooled and measured for absorbance at 532nm using a spectrophotometer (JenwayUV-6305, Essex, England). The malondialdehyde values were calculated using 1, 1, 3, 3-tetraethoxypropane as standard and expressed as nmoles of malondialdehyde/g of liver.

Superoxide dismutase (SOD) activity: Superoxide dismutase (SOD) activity in liver and kidneys supernatant was estimated according to Marklund et al. [18] by assaying the auto oxidation and illumination of pyrogallol at 440nm for 3min. One unit of SOD activity was calculated as the amount of protein that caused 50% pyrogallol auto oxidation inhibition. The SOD activity was expressed as U/mg protein.

Glutathione peroxidase (GPx): Glutathione peroxidase (GPx) activity was performed using H2O2 as substrate according to Paglia et al. [19]. The reaction was monitored indirectly as the oxidation rate of NADPH at 240nm for 3min. The enzyme activity was expressed as nmol/mg protein.

Catalase (CAT): Catalase (CAT) activity was assayed as described by Aebi [20] by assaying the hydrolysis of H2O2 and the resulting decrease in absorbance at 240nm over a 3min at 25 °C. CAT activity was expressed as nmol/mg protein.

Histological studies
Samples from liver and kidneys, intended for histological examination by light microscopy, were immediately fixed in 10% of formalin and processed in a series of graded ethanol solutions. They were then embedded in paraffin, serially sectioned at 6mm and stained with hematoxylin–eosin. Two slides were prepared from each tissue. All sections were evaluated for the degree of organs injury.

Statistical Analysis

Data were analyzed as a completely randomized design using the linear model procedure of SAS (1986). Means were statistically compared using least significant difference (LSD) test at p≤0.05 significance level.


The effects of ML on general rats health
Death was not observed in any experimental group during the treatment period (90 days). However, in ML treated group, few clinical signs such as reduced activity, increasing weakness, slight vomiting and hair loss were observed.

Body weight, Feed intake and weight of liver and kidney
The results indicated that animals treated with ML for 90days showed a significant decrease in body weight, food intake, liver and kidney weights compared to the control group. Animals treated with MO plus ML showed a significant improvement in bodyweight, food intake, liver and kidney weighs (Table 1). ML treatment also decreased the absolute and liver and kidney weight. However, the animals treated with ML plus Mo was restored to normal values compared to controls (Table 1).






Initial Body Weights (g)





Final Body Weights (g)

236.2± 0.2a

233.9± 0.23a

180.9± 0.52b

230.4± 0.43a

Weight Gain (%)





Initial Feed Intake (g/day/rat)





Final Feed Intake (g/day/rat)





Liver Weights (g)





kidney Weights (g)

1.58 ± 0.02a




Table 1: Initial body weights, final body weights, body weight gain, liver and kidney weights and daily feed consumption in adult male rats in different groups during 90 days.
Within each row, means superscribed with different letters are significantly different (P≤ 0.05); control= untreated group, MO= Melissa officinalis; ML= Malathion; MO+ ML= Melissa officinalis + Malathion.

Biochemical parameter in serum
Animals treated with ML showed a significant increase in serum ALT, AST, ALP, creatinine, urea and uric acid while showed significant decrease in acetylcholinestrase activity (Table 2). However, animals treated with Melissa officinalis alone did not show a significant change in all parameter tested. Animals treated with ML showed a significant improvement in all parameter tested compared with control croup. Whereas animal treated with Mo plus Ml did not show a significant improvement in all parameter compared to control (Table 2).







Creatinine (mg/dl)


Uric acid (mg/dl)

Urea (mg/dl)


































Table 2: Effect of Melissa officinalis on serum biochemical parameter in male rats treated with Malathion (27mg/kg bw) for 12 weeks.
Within each column, means superscribed with different letters are significantly different (P≤ 0.05);
AchE =Acetylcholinestrase; ALT= Alanineaminotransaminase; AST= Aspartateaminotransaminase; ALP= Alkaline Phosphatase.

Antioxidant enzymes in liver and kidneys homogenates
The results indicated that in the liver and kidneys homogenates of ML-treated rats, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities had a significant decrease, when compared to controls (Table 3). While treatment with ML resulted in a significant increase in liver and kidneys MDA (Table 3). Treatment with MO alone resulted in a non significant changes in all parameters tested liver and kidneys compared control. Whereas animals treated with ML showed a significant improvements in all parameter tested (Table 3).




(nmol/mg Protein)

(U/mg Protein)

(m mol/mg  Protein)

(nmol/mg Protein)













































Table 3: Effect of Melissa officinalis on MDA, SOD, CAT and GPx in male rats treated with Malathion (27 mg/kgbw) for 12 weeks.

Within each column, means superscribed with different letters are significantly different (P≤0.05); MDA= Malondialdehyde; SOD= superoxide dismutase; CAT= catalase; GPx= glutathione peroxidase

Histological studies
Light microscopic examination indicated a normal structure of the liver and kidneys in the controls group, and those treated with MO alone and MO plus ML (Figure 1A, 1B and 1F), (Figure 2A, 2B and 1D). However, Liver sections of animals treated with ML showed hyperplasia of epithelial lining bile duct and fibroplasia in portal canal (Figure 1C), Kupffer cell activation and focal hepatic necrosis associated with inflammatory cells infiltration (Figure 1D) and focal hepatic necrosis were associated with inflammatory cells infiltration as well as apoptosis of hepatocytes (Figure 1E) in liver. On the other hand, Kidneys sections of animals treated with ML alone showed congestion of glomerular tuft, perivascular oedema associated with inflammatory cells infiltration in kidneys (Figure 2 C), (H & E X 400).

Figure 1: A) A photomicrograph in liver of control rats showed normal central vein and normal hepatocytes. B) The liver sections in the rats treated with Melissa officinalis extract alone showed normal parenchyma and normal focal aggregation of lymphocytes. C) A section of liver of Malathion group showed hyperplasia of epithelial lining bile duct and fibroplasia in portal triad. D) A section of liver of Malathion group showed focal hepatic necrosis associated with inflammatory cells infiltration as well as apoptosis of hepatocytes. E) A section of liver of Malathion group showed Kupffer cell activation and few leucocytes in hepatic sinusoids. F) A section of liver of rats treated with Malathion plus Melissa officinalis showed slight congestion of hepatic sinusoids (arrow).  (H & E X 400).
Figure 2: A) A section of Kidney of rats in control group the normal histological structure   of renal parenchyma. B) A section of Kidney of rats treated with Melissa officinalis extract alone showed no histopathological changes. C) A section of Kidney of rats treated with Malathion alone showed congestion of glomerular tuft, perivascular oedema associated with few inflammatory cells infiltration (arrows). D) A section of Kidney of rats treated with Melissa officinalis extract plus Malathion showed no histopathological changes (H & E X 400).


The widespread use of malathion has led to the exposure of animals, birds, and non-target invertebrates to this pesticidal chemical and the contamination of human food sources [21]. Mammals are likely to be adversely affected by oral, dermal, and inhalation exposure to Malathion [22]. While the oral LD50 of malathion for male rat is 1350mg/kg. Malathion is an organophosphorothionate pesticide with relative low toxicity, can be activated by the cytochrome P450 system by oxidative desulfuration to form malaoxon, an effective inhibitor of AchE [23].

In the present study, we have explored the effects of a sub chronic exposure of malathion at 27mg/kg bw (1/50 of the oral LD50) for 90days on liver and kidneys toxicities in male rats. Present study showed that sub chronic exposure to malathion was able to induce a significant decrease in body weight, food intake, liver and kidney weights in ML-treated group compared control group. This could be due to decreased water and food intake in these animals. Many studies have shown that OP insecticides cause reduction of body weight in experimental animals [24].

The weight reduction in ML-treated rats may be due to reduced appetite of rats [12], a result of choline esterase inhibition [24] and the toxic effect or hormonal imbalance in any step in the hypothalamo–hypophysial–testicular axis [25].

The result of the present study showed a significant increase in serum ALT, AST and ALP in ML-treated animals when compared with another groups. A significant increase in serum activities of AST and ALT considered like markers enzymes of hepatocyte cytolysis. Indeed, AST and ALT are two hepatic enzymes which will be released in blood in the event of cellular destruction proportionally to the intensity of the cellular aggression [26]. The recorded increase of AST and ALT levels may be due to increased LPO. When the liver cell membrane is damaged, several enzymes located in the hepatocyte cytosol, including, ALT, AST and ALP, are secreted into the blood [27]. Consequently, these serum enzymes are markers of liver damage. It has been shown that OP insecticides can elevate the enzymatic activities of ALP, ALT, and AST [27]. Moreover, malathion raises the ALT and AST levels in rats [28]. Indeed, we have seen a high positive correlation between serum rates of AST and ALT and hepatic MDA level. This is consistent with the damage to the hepatic tissues in the malathion-treated rats seen by light microscopy.

Like other OP compounds, malathion is known to inhibit AchE [29]. In this study, we also demonstrated the inhibition of AChE in rat treated with malathion alone versus another groups. Inhibition of AchE by OP leads to an accumulation of acetylcholine and subsequent impairment of numerous body functions [30].

The present results showed that there was a statistically significant enhance in serum creatinine, urea and acid uric levels. Parameters like urea, uric acid and creatinine levels are significant indicators to evaluate kidney functions [31]. In context, enhanced urea, uric acid and creatinine concentrations have been used to indicate renal dysfunction. As being major metabolic product of protein metabolism, blood urea nitrogen studied to indicate glomerular damage [32]. Blood urea nitrogen, uric acid and creatinine levels were significantly increased after 12 weeks malathion treatment (27mg/kg bw). Enhanced urea level correlated with elevated protein catabolism and/or the conversion of ammonia to urea as a result of elevated synthesis of arginase enzyme involved in urea production [33]. Creatinine is an end metabolic product of muscle catabolism and is removed at a constant rate by the kidneys [34]. The creatinine excretion is dependent on the process of glomerular filtration. The elevated creatinine level shows that damage of the glomerular function and tubular damage [35]. Uric acid is the major metabolic product of purine nucleotides [36]. Impairment in kidney function could probably occur via kidney oxidative damage. This compound is the end product of purine catabolism and can reduce oxidative stress by scavenging various ROS [37]. Antioxidants constitute the foremost defense system that limits the toxicity associated with free radicals [38]. Moreover, the cellular antioxidant status determines the susceptibility to oxidative damage and is usually altered in response to oxidative stress. Our results indicated that a significant increase of MDA activity and a significant decrease in SOD, GPx and catalase in liver and kidneys of animals treated with ML at end of the experimental period, those results consistent with those reported by Rosety et al. [39].

CAT is a hematin-containing enzyme located in peroxisomes and facilitates the removal of hydrogen peroxide (H2O2), which is metabolized to molecular oxygen (O2) and water. Therefore, the SOD-CAT system provides the first defense against oxygen toxicity. CAT activity is directly regulated by the concentration of H2O2 [40]. The present results showed that the tendency of CAT was consistent with the changes of SOD activity. This suggested that H2O2 generated by SOD was removed by CAT directly.

GPx and CAT have complementary roles in H2O2 detoxification. In the present study, the results showed that GPx activity had a significant decrease under Malathion stress. This suggested that GPx play an important role in detoxifying H2O2 caused by malathion-induced oxidative stress. The decreased activities of GPx indicate its reduced capacity to scavenge H2O2 and lipid hydroperoxides [41]. GPx is a seleno anti peroxidative enzyme that is present both in cytosol and mitochondrial matrix [34]. The main function of GPx is to reduce hydrogen peroxide. Decreased GPx level was determined in ML-treated rats. ML may inhibit the GPx directly by impairing the functional groups [42]. Also the reduction in the CAT and GPx activities may occurred as a defence response used against hydrogen peroxide generated by ML [43].

The elevated level of MDA might be due to enhanced formation of free radicals. Malathion-induced escalation of MDA level could be used as an indicator of malathion damage. Jihen et al. [44] reported that some antioxidant enzymes, such as SOD, CAT, and GPx, play a crucial role in anti oxidation and elimination of reactive oxygen species. SOD, CAT and GPx activities decreased in various rat tissues mercuric chloride-treated [45]. SOD, CAT and GPx activities decreased in the kidney tissues of ML treated rats. SOD catalyzes the conversion of superoxide anion into hydrogen peroxide. Hydrogen peroxide is converted to water by CAT [46]. CAT is responsible for equilibration the formation of hydrogen peroxide and superoxide radicals. In our study, the inhibition of SOD and CAT activities might be due to overwhelming reactive oxygen species production.

Recently, De CarvalhoI et al. [47] have demonstrated that M. officinalis exhibits antigenotoxic/ antimutagenic properties in mice. So in our work the effect of melissa extract as a main source of antioxidants against malathion hazard in rat testes was studied and found that the M. officinalis extract has antioxidant activity agent and could improve the biochemical and histochemical picture of rat testes against toxicity of malathion.

OP insecticides are known to induce various histopathological changes in the liver tissues [48] and indeed we found by light microscopic analyses that malathion-induced hyperplasia of epithelial lining bile duct and fibroplasia in portal triad and Kupffer cell activation and focal hepatic necrosis associated with inflammatory cells infiltration and focal hepatic necrosis associated with inflammatory cells infiltration as well as apoptosis of hepatocytes in Liver sections of animals treated with ML when compared with control group. On the other hand Kidneys sections of animals treated with ML alone showed congestion of glomerular tuft, perivascular oedema associated with inflammatory cells infiltration in kidneys when compared with control group. The sections of liver and kidneys of animal treated with MO or MO plus ML showed improvements in histological picture. The basis of histological changes may be due to increased lipid peroxidation ML induced. These changes harmonize with our biochemical examinations [49].

In previous study, Seif et al.reported that male rats exposed to malathion for 12 weeks was caused testicular toxicity, and the Melissa officinalis extract posses the protective role against toxicity of malathion on rat testes since it contains the antioxidant components and could improve the sperm counts, motility and morphology. And also protect malathion-exposed rats from the effects of malathion on FSH, LH and testosterone levels.


The present study showed that ML intoxication caused reactive oxygen species generation which in turn induced histopathological and biochemical alterations in rats liver and kidneys. Administration of Melissa officinalis L. extract proved to be beneficial in attenuating the Malathion induced hepatorenal toxicity


The authors wish to express their appreciation to Prof. Khayria M. Naguib. Head of Mycotoxins Central Lab., National Research Center, Cairo, Egypt for her great supports for this work.


  1. Lu TH, Tseng TJ, Su CC, Tang FC, Yen CC, et al. (2014) Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways. Toxicol Lett 224(1): 130-140.
  2. Walton FS, Harmon AW, Paul DS, Drobna Z, Patel YM, et al. (2004) Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 198(3): 424-433.
  3. TSENG CH (2004) The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicology and applied pharmacology 197(2): 67-83.
  4. Paul DS, Hernandez-Zavala A, Walton FS, Adair BM, Dedina J, et al. (2007) Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol 222(3): 305-314.
  5. Li YN, Xi MM, Guo Y, Hai CX, Yang WL, et al. (2014) NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1α stabilization by inhibiting prolyl hydroxylases activity. Toxicol Lett 224(2): 165-174.
  6. David S Paul, Anne W Harmon, Vicenta Devesa, David J Thomas, Miroslav Stýblo (2007) Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115(5): 734-742.
  7. Singh N, Kumar D, Lal K, Raisuddin S, Sahu AP (2010) Adverse health effects due to arsenic exposure: modification by dietary supplementation of jaggery in mice. Toxicology Appl pharmacol 242(3): 247-255.
  8. Shi H, Shi X, Liu KJ (2004) Oxidative mechanism of arsenic toxicity and carcinogenesis Mol Cell Biochem 255(1-2): 67-78.
  9. Yoshida T, Yamauchi H, Fan Sun G (2004) Chronic health effects in people exposed to arsenic via the drinking water: dose–response relationships in review. Toxicol Appl Pharmacol 198(3): 243-252.
  10. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME (2009) Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674(1-2): 85-92.
  11. FLORA SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51(2): 257-281.
  12. Lu TH, Su CC, Chen YW, Yang CY, Wu CC (2011) Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways. Toxicol Lett 201(1): 15-26.
  13. Majumdar S, Karmakar S, Maiti A, Choudhury M, Ghosh A (2011) Arsenic-induced hepatic mitochondrial toxicity in rats and its amelioration by dietary phosphate. Environ Toxicol Pharmacol 31(1): 107-118.
  14. Ramanathan K, Shila S, Kumaran S, Panneerselvam C (2003) Ascorbic acid and α-tocopherol as potent modulators on arsenic induced toxicity in mitochondria. J Nutr Biochem 14(7): 416-420.
  15. Gao C, Zhong L, Jiang L, Geng C, Yao X, et al. (2013) Phellinus linteus mushroom protects against tacrine-induced mitochondrial impairment and oxidative stress in HepG2 cells. Phytomedicine 20(8-9): 705-709.
  16. Othman MS, Safwat G, Aboulkhair M, Abdel Moneim AE (2014) The potential effect of berberine in mercury-induced hepatorenal toxicity in albino rats. Food Chem Toxicol 69: 175-181.
  17. Amritpal Singh, Sanjiv Duggal, Navpreet Kaur, Jaswinder Singh (2010) Berberine: Alkaloid with wide spectrum of pharmacological activities. I Journal of Natural Products 3: 64-75.
  18. Mittal A, Tabasum S, Singh RP (2014) Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft. Phytomedicine 21(3): 340-347.
  19. Malik TA, Kamili AN, Chishti MZ, Tanveer S, Ahad S, et al. (2014) In vivo anticoccidial activity of berberine [18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium]–An isoquinoline alkaloid present in the root bark of Berberis lycium. Phytomedicine 21(5): 663-669.
  20. Chen G, Lu F, Xu L, Dong H, Yi P, et al. (2013) The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility. Phytomedicine 20(10): 780-786.
  21. Pund S, Borade G, Rasve G (2014) Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nano emulsifying technique. Phytomedicine 21(3): 307-314.
  22. Wang YX, Wang YP, Zhang H, Kong WJ, Li YH, et al. (2009) Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor. Bioorg Med Chem Lett 19(21): 6004-6008.
  23. Yin J, Xing H, Ye J (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57(5): 712-717.
  24. Hu Y, Ehli EA, Kittelsrud J, Ronan PJ, Munger K, et al. (2012) Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine 19(10): 861-867.
  25. Jun Yina, Jianping Yeb, Weiping Jia (2012) Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica B 2(4): 327-334.
  26. Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS (2012) Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta 1822(2): 185-195.
  27. Domitrović R, Jakovac H, Blagojević G (2011) Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl(4) intoxicated mice. Toxicology 280(1-2): 33-43.
  28. Zhou J1, Zhou S, Tang J, Zhang K, Guang L, et al. (2009) Protective effect of berberine on beta cells in streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 606(1-3): 262-268.
  29. Ghosh S, Dungdung SR, Chowdhury ST, Mandal AK, Sarkar S, et al. (2011) Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic Biol Med 51(10): 1893-1902.
  30. Dwivedi N, Mehta A, Yadav A, Binukumar BK, Gill KD, et al. (2011) MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats. Toxicol Appl Pharmacol 256(3): 241-248.
  31. Baracca A, Sgarbi G, Solaini G, Lenaz G (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta 1606(1-3): 137-146.
  32. Dutta M, Ghosh D, Ghosh AK, Bose G, Chattopadhyay A, et al. (2014) High fat diet aggravates arsenic induced oxidative stress in rat heart and liver. Food Chem Toxicol 66: 262-277.
  33. Ghosh D, Ghosh S, Sarkar S, Ghosh A, Das N, et al. (2010) Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem Biol Interact 186(1): 61-71.
  34. Selvaraj V, Armistead MY, Cohenford M, Murray E (2013) Arsenic trioxide (As(2)O(3)) induces apoptosis and necrosis mediated cell death through mitochondrial membrane potential damage and elevated production of reactive oxygen species in PLHC-1 fish cell line. Chemosphere 90(3): 1201-1209.
  35. Pan X, Dai Y, Li X, Niu N, Li W, et al. (2011) Inhibition of arsenic induced-rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-β/Smad activation. Toxicol Appl Pharmacol 254(3): 323-331.
  36. Paul MK, Kumar R, Mukhopadhyay AK (2008) Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Toxicol Appl Pharmacol 226(2): 140-152.
  37. Banerjee N, Banerjee M, Ganguly S, Bandyopadhyay S, Das JK, et al. (2008) Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. Toxicology 246(2-3): 101-111.
  38. Bustamante J, Nutt L, Orrenius S, Gogvadze V (2005) Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol 207(2 Suppl): 110-116.
  39. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK (2007) Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 220(2): 146-155.
  40. Thirupurasundari CJ, Padmini R, Devaraj SN (2009) Effect of berberine on the antioxidant status, ultra structural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats. Chem Biol Interact 177(3): 190-195.
  41. Cheng F, Wang Y, Li J, Su C, Wu F, et al. (2013) Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 167(3): 936-942.
  42. Hsu YY, Chen CS, Wu SN, Jong YJ, Lo YC (2012) Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells. Eur J Pharm Sci 46(5): 415-425.
  43. Dröse S (2013) Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning. Biochim Biophys Acta 1827(5): 578-587.
  44. Kysenius K, Brunello CA, Huttunen HJ (2014) Mitochondria and NMDA Receptor-Dependent Toxicity of Berberine Sensitizes Neurons to Glutamate and Rotenone Injury. PLoS One 9(9): e107129.
  45. Pereira GC, Branco AF, Matos JA, Pereira SL, Parke D, et al. (2007) Mitochondrially targeted effects of berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J Pharmacol Exp Ther 323(2): 636-649.
  46. Jantova S, Cipak L, Letasiova S (2007) Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol In Vitro 21(1): 25-31.
  47. Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS, et al. (2012) Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 83(3): 385-394.
  48. Meeran SM, Katiyar S, Katiyar SK (2008) Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Meeran SM, Katiyar S, Katiyar SK 229(1): 33-43.
  49. Li Q, Zhang L, Zu Y, Liu T, Zhang B, et al. (2013) Generation of reactive oxygen species by a novel berberine–bile acid analog mediates apoptosis in hepato carcinoma SMMC-7721 cells. Biochem Biophys Res Commun 433(4): 432-437.
© 2014-2018 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy